Smart Inhalers Market Grows at 42.8% CAGR Majorly Due To Technological Advancements Globally Till 2023

“Smart Inhalers Market”
MRFR is the Leading Brand in The Research Company who Recently Published Smart Inhalers Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023.

Market Research Future (MRFR) has published a research report about the global smart inhalers market. According to this report, the market is expected to rise by 42.8% CAGR (Compound Annual Growth Rate) growth during the forecast period (2016 – 2022). Approximate growth figure by 2022 is estimated to be the US $1636.1 mn. As per statistics, dry powder inhalers hold the largest share of the market.

In a consumerist world, consumers depend more and more on devices and after smartphone, smart cards, smart TV, smart watch, smart pads, smart boards, smart sensors and air conditioners, the world has recently witnessed an innovation called smart inhalers which is boon for people suffering from respiratory diseases like asthma.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2117

Global Smart Inhalers Market – Key Players

Adherium Limited (New Zealand), AstraZeneca (England), Cohero Health (USA), GlaxoSmithKline (U.K.), Gecko Health Innovations Inc (USA), Inspiro Medical Ltd., and Propeller Health (USA) are some of the prominent players at the forefront of competition in the Global Smart Inhalers Market and are profiled in MRFR Analysis. 

Latest Industry News:

Adherium’s partnering and market expansion for the ‘Rest of World’ territories, including countries in Asia Pacific and the Middle East where Adherium already has sanctions to market its Smartinhaler products in China, Australia and New Zealand. This will increase the company’s strength in these countries.

Moreover, AstraZeneca, multinational pharmaceutical and biopharmaceutical Company had recently started its expansion in respiratory business with the acquisition of respiratory business of Tadeka Pharmaceuticals in 2016, and also with partnership with Adherium, for the supplies of smart inhaler and sensors.

In January 2017, AstraZeneca announced that on 25 January 2017 the US Food and Drug Administration (FDA) granted six months of paediatric exclusivity for Symbicort (budesonide/formoterol) Inhalation Aerosol. Symbicort is approved in the US to treat asthma in patients 12 years and older and for the maintenance and treatment of COPD in adults, the company is expecting larger market share with the product launch.

Gecko Health Innovations, Inc., acquired by Teva Pharmaceutical in 2015, focusing on cloud-based solution to simplify chronic respiratory disease management, and connect patients and caregivers through remote monitoring and real-time tools. The major driving factors for the company’s growth in the market are due to increasing technological advancements and need for integrated cloud-based technologies in the treatment of respiratory diseases.

Global Smart Inhalers Market – Key Finding

  • The Smart Inhalers global market and is expected to reach $1636.1 million by 2022.
  • Dry Powder Inhalers hold the largest share of the market.
  • North America holds the largest market share of 54.3% of smart inhalers market and is anticipated to reach $888.4 million by the end of forecast period.
  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 55.3% during the forecast period.

Global Smart Inhalers Market – Segments

Smart Inhalers Market has been segmented on the basis of type which comprises of dry powder inhaler, and metered dose inhaler. On the basis of application, market is segmented into Asthma, COPD, and others. On the basis of end user, market is segmented into hospitals & clinics, respiratory care center, and others.

Browse Complete 81  Pages Premium Research Report Enabled with Tables and Figures @https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117

Global Smart Inhalers Market – Regional Analysis

Globally North America is the largest market for Smart Inhalers which is anticipated to reach $888.4 million by 2023. Europe is the second-largest market in 2016 which is valued at $57.4 million. Furthermore, Asia pacific market is expected to be the fastest growing market and is projected to grow at a CAGR of 55.3% during the forecast period from 2016-2022. Smart inhalers market in rest of world is expected to rise after 2019.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/2117

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/big-data-as-a-service-market-1209